eCite Digital Repository

Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation

Citation

Bezabhe, WM and Bereznicki, LR and Radford, J and Salahudeen, MS and Garrahy, E and Wimmer, BC and Bindoff, I and Peterson, GM, Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation, Internal Medicine Journal, 51, (10) pp. 1732-1735. ISSN 1444-0903 (2021) [Refereed Article]

Copyright Statement

2021 Royal Australasian College of Physicians

DOI: doi:10.1111/imj.15514

Abstract

Despite changes in antiarrhythmic drug (AAD) choice in patients with atrial fibrillation (AF), trends in AAD prescribing remain not investigated. We aimed to examine these changes using a nationwide Australian general practice data from 2009 to 2018. Over the 10 years, AAD prescribing in patients with AF decreased, which was mainly due to a reduction in the use of amiodarone, sotalol and digoxin. In contrast, the use of beta-blockers and flecainide increased.

Item Details

Item Type:Refereed Article
Keywords:antiarrhythmic drugs, atrial fibrillation, primary care, arrhythmia
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacology and therapeutics
Objective Division:Health
Objective Group:Clinical health
Objective Field:Diagnosis of human diseases and conditions
UTAS Author:Bezabhe, WM (Dr Woldesellassie Bezabhe)
UTAS Author:Bereznicki, LR (Professor Luke Bereznicki)
UTAS Author:Radford, J (Associate Professor Jan Radford)
UTAS Author:Salahudeen, MS (Dr Mohammed Salahudeen)
UTAS Author:Garrahy, E (Dr Edward Garrahy)
UTAS Author:Wimmer, BC (Dr Barbara Wimmer)
UTAS Author:Bindoff, I (Dr Ivan Bindoff)
UTAS Author:Peterson, GM (Professor Gregory Peterson)
ID Code:147290
Year Published:2021
Deposited By:Pharmacy
Deposited On:2021-10-23
Last Modified:2021-11-19
Downloads:0

Repository Staff Only: item control page